Proactive Investors - Run By Investors For Investors

Elixinol Global 'only company in the sector to list a profit'

Elixinol Global Ltd (ASX:EXL) executive director & CEO Paul Benhaim speaks to Proactive Investors about the cannabis group of companies’ business sectors and suite of hemp-based foods, supplements and medicinal oil products.
The group’s portfolio comprises three main divisions: Elixinol USA focused on dietary supplements; Hemp Foods Australia selling food products; and Elixinol Australia, the new start-up focused on medicinal cannabis.
“Elixinol Global listed in January this year on the ASX and we did that to raise about $20 million which was a highly oversubscribed listing,” Benhaim says.
He continues, “those funds were intended to be used on the medical cannabis business start-up in Australia … that business has applied for licences with the Office of Drug  Control, which we’re currently waiting for.”
Recently announced half-year results show Elixinol Global grew over 110% on the prior period, with first-half revenue of $14.9 million.
Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
Meet Carnarvon Petroleum Ltd, Bass Oil Ltd, High Peak Royalties Ltd, Global Energy Ventures Ltd and Po Valley Energy Ltd at our event, Melbourne , 12 March 2019. Register here »
View full EXL profile View Profile

Elixinol Global Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use